Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 624819, 8 pages
http://dx.doi.org/10.1155/2015/624819
Research Article

Neuroprotective Effect of Ulinastatin on Spinal Cord Ischemia-Reperfusion Injury in Rabbits

1Department of Anesthesiology, The 2nd People’s Hospital of Guangdong Province, Guangdong Provincial Emergency Hospital, Guangzhou 510317, China
2Department of Anesthesiology, Huizhou Municipal Central Hospital, Huizhou 516001, China
3Department of Anesthesiology, The First People’s Hospital of Shangqiu, Shangqiu 476000, China
4Department of Anesthesiology, Affiliated Hospital of Guangdong Medical College, Zhanjiang 524003, China
5Department of Anesthesiology, The University of Hong Kong, Hong Kong

Received 17 September 2014; Revised 8 January 2015; Accepted 8 January 2015

Academic Editor: Mengzhou Xue

Copyright © 2015 Bingbing Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. B-Rao and J. Stewart, “Inverse analysis of empirical matrices of idiotypic network interactions,” Bulletin of Mathematical Biology, vol. 58, no. 6, pp. 1123–1153, 1996. View at Publisher · View at Google Scholar · View at Scopus
  2. P. D. Smith, F. Puskas, X. Meng et al., “The evolution of chemokine release supports a bimodal mechanism of spinal cord ischemia and reperfusion injury,” Circulation, vol. 126, pp. S110–S117, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Kakinohana, K. Kida, S. Minamishima et al., “Delayed paraplegia after spinal cord ischemic injury requires caspase-3 activation in mice,” Stroke, vol. 42, no. 8, pp. 2302–2307, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Lang-Lazdunski, K. Matsushita, L. Hirt, C. Waeber, J.-P. G. Vonsattel, and M. A. Moskowitz, “Spinal cord ischemia: development of a model in the mouse,” Stroke, vol. 31, no. 1, pp. 208–213, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. M. F. Conrad, J. Y. Ye, T. K. Chung, J. K. Davison, and R. P. Cambria, “Spinal cord complications after thoracic aortic surgery: long-term survival and functional status varies with deficit severity,” Journal of Vascular Surgery, vol. 48, no. 1, pp. 47–53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Hayashi, M. Sakurai, K. Abe, M. Sadahiro, K. Tabayashi, and Y. Itoyama, “Apoptosis of motor neurons with induction of caspases in the spinal cord after ischemia,” Stroke, vol. 29, no. 5, pp. 1007–1013, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Zong, G. Zeng, Y. Fang et al., “The role of IL-17 promotes spinal cord neuroinflammation via activation of the transcription factor STAT3 after spinal cord injury in the rat,” Mediators of Inflammation, vol. 2014, Article ID 786947, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Oda, K. Yamashita, T. Inoue et al., “Resuscitation fluid volume and abdominal compartment syndrome in patients with major burns,” Burns, vol. 32, no. 2, pp. 151–154, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Endo, K. Inada, K. Taki, S. Hoshi, and M. Yoshida, “Inhibitory effects of ulinastatin on the production of cytokines: implications for the prevention of septicemic shock,” Clinical Therapeutics, vol. 12, no. 4, pp. 323–326, 1990. View at Google Scholar · View at Scopus
  10. Y.-Z. Cao, Y.-Y. Tu, X. Chen, B.-L. Wang, Y.-X. Zhong, and M.-H. Liu, “Protective effect of Ulinastatin against murine models of sepsis: inhibition of TNF-α and IL-6 and augmentation of IL-10 and IL-13,” Experimental and Toxicologic Pathology, vol. 64, no. 6, pp. 543–547, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. Q.-L. He, F. Zhong, F. Ye et al., “Does intraoperative ulinastatin improve postoperative clinical outcomes in patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials,” BioMed Research International, vol. 2014, Article ID 630835, 15 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. H.-M. Luo, M.-H. Du, Z.-L. Lin et al., “Ulinastatin suppresses burn-induced lipid peroxidation and reduces fluid requirements in a swine model,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 904370, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. Z.-L. Cao, Y. Okazaki, K. Naito, T. Ueno, M. Natsuaki, and T. Itoh, “Ulinastatin attenuates reperfusion injury in the isolated blood-perfused rabbit heart,” Annals of Thoracic Surgery, vol. 69, no. 4, pp. 1121–1126, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. O. A. R. Binns, N. F. DeLima, S. A. Buchanan et al., “Neutrophil endopeptidase inhibitor improves pulmonary function during reperfusion after eighteen-hour preservation,” The Journal of Thoracic and Cardiovascular Surgery, vol. 112, no. 3, pp. 607–613, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Kudo, T. Egashira, and Y. Yamanaka, “Protective effect of ulinastatin against liver injury caused by ischemia-reperfusion in rats,” Japanese Journal of Pharmacology, vol. 60, no. 3, pp. 239–245, 1992. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Nakahama, K. Obata, and M. Sugita, “Ulinastatin ameliorates acute ischemic renal injury in rats,” Renal Failure, vol. 18, no. 6, pp. 893–898, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Yano, S. Anraku, R. Nakayama, and K. Ushijima, “Neuroprotective effect of urinary trypsin inhibitor against focal cerebral ischemia-reperfusion injury in rats,” Anesthesiology, vol. 98, no. 2, pp. 465–473, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Yao, G. Luo, G. Zhu et al., “Propofol activation of the Nrf2 pathway is associated with amelioration of acute lung injury in a rat liver transplantation model,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 258567, 9 pages, 2014. View at Publisher · View at Google Scholar
  19. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  20. T. Luo, Z. Xia, D. M. Ansley et al., “Propofol dose-dependently reduces tumor necrosis factor-α-induced human umbilical vein endothelial cell apoptosis: effects on Bcl-2 and bax expression and nitric oxide generation,” Anesthesia and Analgesia, vol. 100, no. 6, pp. 1653–1659, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Liu, B. Zhou, Z.-Y. Xia et al., “Hyperglycemia-induced inhibition of DJ-1 expression compromised the effectiveness of ischemic postconditioning cardioprotection in rats,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 564902, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Li, Z. Liu, J. Wang et al., “Susceptibility to myocardial ischemia reperfusion injury at early stage of type 1 diabetes in rats,” Cardiovascular Diabetology, vol. 12, no. 1, article 133, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. N. T. Kouchoukos, J. R. Scharff, and C. F. Castner, “Repair of primary or complicated aortic coarctation in the adult with cardiopulmonary bypass and hypothermic circulatory arrest,” The Journal of Thoracic and Cardiovascular Surgery, 2014. View at Publisher · View at Google Scholar
  24. H. Kertmen, B. Gürer, E. R. Yilmaz et al., “The protective effect of low-dose methotrexate on ischemia-reperfusion injury of the rabbit spinal cord,” European Journal of Pharmacology, vol. 714, no. 1–3, pp. 148–156, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. E. D. Hall and J. E. Springer, “Neuroprotection and acute spinal cord injury: a reappraisal,” NeuroRx, vol. 1, no. 1, pp. 80–100, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. C. A. Oyinbo, “Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade,” Acta Neurobiologiae Experimentalis, vol. 71, no. 2, pp. 281–299, 2011. View at Google Scholar · View at Scopus
  27. R. D. Azbill, X. Mu, A. J. Bruce-Keller, M. P. Mattson, and J. E. Springer, “Impaired mitochondrial function, oxidative stress and altered antioxidant enzyme activities following traumatic spinal cord injury,” Brain Research, vol. 765, no. 2, pp. 283–290, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. Q. Fan, X.-C. Yang, Y. Liu et al., “Postconditioning attenuates myocardial injury by reducing nitro-oxidative stress in vivo in rats and in humans,” Clinical Science, vol. 120, no. 6, pp. 251–261, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Lei, H. Li, J. Xu et al., “Hyperglycemia-induced protein kinase C β2 activation induces diastolic cardiac dysfunction in diabetic rats by impairing caveolin-3 expression and Akt/eNOS signaling,” Diabetes, vol. 62, no. 7, pp. 2318–2328, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. E. R. Yilmaz, H. Kertmen, H. Dolgun et al., “Effects of darbepoetin-alpha in spinal cord ischemia-reperfusion injury in the rabbit,” Acta Neurochirurgica, vol. 154, no. 6, pp. 1037–1044, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Diaz-Ruiz, C. Rios, I. Duarte et al., “Lipid peroxidation inhibition in spinal cord injury: cyclosporin-A vs methylprednisolone,” NeuroReport, vol. 11, no. 8, pp. 1765–1767, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Yamauchi, Y. Izumi, M. Inoue et al., “Safety of postoperative administration of human urinary trypsin inhibitor in lung cancer patients with idiopathic pulmonary fibrosis,” PLoS ONE, vol. 6, no. 12, Article ID e29053, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Koga, M. Fujita, R. Tsuruta et al., “Urinary trypsin inhibitor suppresses excessive superoxide anion radical generation in blood, oxidative stress, early inflammation, and endothelial injury in forebrain ischemia/reperfusion rats,” Neurological Research, vol. 32, no. 9, pp. 925–932, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Xu, B. Ren, M. Li, F. Jiang, Z. Zhanng, and J. Hu, “Ulinastatin suppresses systemic inflammatory response following lung ischemia-reperfusion injury in rats,” Transplantation Proceedings, vol. 40, no. 5, pp. 1310–1311, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Kannan and S. K. Jain, “Oxidative stress and apoptosis,” Pathophysiology, vol. 7, no. 3, pp. 153–163, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Antonsson and J. C. Martinou, “The Bcl-2 protein family,” Experimental Cell Research, vol. 256, no. 1, pp. 50–57, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. D. R. Green and J. C. Reed, “Mitochondria and apoptosis,” Science, vol. 281, no. 5381, pp. 1309–1312, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. C.-C. Chen, Z.-M. Liu, H.-H. Wang, W. He, Y. Wang, and W.-D. Wu, “Effects of ulinastatin on renal ischemia-reperfusion injury in rats,” Acta Pharmacologica Sinica, vol. 25, no. 10, pp. 1334–1340, 2004. View at Google Scholar · View at Scopus
  39. Y. Wang, X. Liu, D. Zhang, J. Chen, S. Liu, and M. Berk, “The effects of apoptosis vulnerability markers on the myocardium in depression after myocardial infarction,” BMC Medicine, vol. 11, no. 1, article 32, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. G. M. Cohen, “Caspase: the executioners of apoptosis,” Biochemical Journal, vol. 326, no. 1, pp. 1–16, 1997. View at Google Scholar · View at Scopus